PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32556678-10	2020	This finding suggests the potential therapeutic role of lncRNA MIAT and miR-330-5p in LPS-induced myocardial injury.	lps	86-89	microRNA 330	Mus musculus	72-79	
32556678-8	2020	Knockdown of MIAT or overexpression of miR-330-5p restrained inflammation and oxidative stress induced by LPS in vitro; MIAT directly targeted miR-330-5p to regulate NF-kappaB signaling, and miR-330-5p targeted against TRAF6 to suppress the activation of NF-kappaB signaling.	lps	106-109	microRNA 330	Mus musculus	39-46	
32556678-8	2020	Knockdown of MIAT or overexpression of miR-330-5p restrained inflammation and oxidative stress induced by LPS in vitro; MIAT directly targeted miR-330-5p to regulate NF-kappaB signaling, and miR-330-5p targeted against TRAF6 to suppress the activation of NF-kappaB signaling.	lps	106-109	microRNA 330	Mus musculus	143-150	
32556678-8	2020	Knockdown of MIAT or overexpression of miR-330-5p restrained inflammation and oxidative stress induced by LPS in vitro; MIAT directly targeted miR-330-5p to regulate NF-kappaB signaling, and miR-330-5p targeted against TRAF6 to suppress the activation of NF-kappaB signaling.	lps	106-109	microRNA 330	Mus musculus	143-150	
32556678-9	2020	We determined that lncRNA MIAT directly binds to miR-330-5p to activate TRAF6/NF-kappaB signaling axis and further promotes inflammation response as well as oxidative stress in LPS-induced septic cardiomyopathy.	lps	177-180	microRNA 330	Mus musculus	49-56